160 HEALTH Reports Narrowed Annual Loss of 72.986 Million Yuan

Stock News
03/27

160 HEALTH (02656) announced its financial results for the year ended December 31, 2025. The group recorded revenue of 652 million yuan, representing a 5% year-on-year increase. The loss attributable to company owners was 72.986 million yuan, narrowing by 32.22% compared to the previous year. The loss per share was 0.24 yuan. According to the announcement, the revenue growth was primarily driven by strong performance in the company's digital healthcare solutions and pharmaceutical health product sales.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10